Table 1. Patient demographics (N=116).
| Variable | N (%) |
|---|---|
| Age, year, mean ± SD | 69.4±10.7 |
| Gender | |
| Male | 76 (65.5) |
| Female | 40 (34.5) |
| Race | |
| White | 101 (87.1) |
| Black | 10 (8.6) |
| Hispanic | 4 (3.4) |
| Indian | 1 (0.9) |
| Location | |
| Esophageal | 49 (42.2) |
| Pancreatic | 34 (29.3) |
| Colorectal | 14 (12.1) |
| Gastric | 13 (11.2) |
| Biliary | 6 (5.2) |
| Histology | |
| Adeno. | 98 (84.5) |
| Neuroendocrine | 5 (4.3) |
| Cholangio. | 4 (3.4) |
| HCC | 4 (3.4) |
| GIST | 3 (2.6) |
| Squamous | 2 (1.7) |
| Node/Mets status | |
| LN negative | 36 (31.0) |
| LN positive | 52 (44.8) |
| Metastatic disease | 28 (24.2) |
HCC, hepatocellular carcinoma; GIST, gastrointestinal stromal tumor.